Xu Shen was born in March of 1964, Anhui, China. He is currently a full professor and director of 3rd Pharmacology Department of Shanghai Institute of Materia medica (SIMM), Chinese Academy of Sciences (CAS). He got his Ph.D degree in July of 1995 from SIMM. From 1995.9-1997.7, Dr. Shen worked as a postdoc researcher in Fujian Institute of Research on the Structure of Matter, CAS, and then moved to work in Shanghai Tongji University, China. From 1999.1-2001.11, Dr. Shen pursued his further postdoc research on molecular pharmacology and structural biology in Osaka University of Pharmaceutical Sciences, Japan and Weill Medical College of Cornell University, USA. For over 10-year experiences in drug discovery field against infection and metabolic diseases, Dr. Shen has made a number of fundamental contributions to the understanding of the roles of SARS potent proteins in the development of anti-SARS drug and performed the relevant nuclear receptor (PPAR, ER, GR, etc) based research against anti-diabetes drug lead compound discovery. Dr. Shen has published more than 100 peer-review original papers and invited reviews, and obtained 7 patents. He has been granted several potent honorary titles and awards for his contributions in scientific research such as “Shanghai leading talent” (2007), the Second Prize of National Natural Science Award (3rd participator) (2007), the First Prize of Debio-CCRF China Award (2007), Excellent Supervisor for Graduate Student of CAS (2006), and the First Prize of Shanghai Science and Technology Progress Award (3rd participator) (2004), etc. Dr. Shen is also honoured as a specially-appointed professor of the school of pharmacy, East China University of Science and Technology, and a visiting professor of Shanghai University of Traditional Chinese Medicine. He is a member of Editorial Board of Journal of Microbes and Infection, PPAR research and Acta pharmacologica Sinica.
Biography Updated on 4 February 2009